Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 24, 2022

View Archived Issues

Brain-derived extracellular vesicles participate in the prion-like propagation of tau in tauopathies

EVs and their miRNAs released by inflammatory-primed stem cells may reverse brain inflammation

R8H283 antibody targets multiple myeloma cells through CD98 recognition

GSNOR deficiency tied to pre-eclampsia

CAR T cells targeting GRP78 show activity against acute myeloid leukemia in vivo

Sanofi patents YAP1/TAZ and TEAD interaction inhibitors

Adorx Therapeutics discloses adenosine receptor A2A and/or A2B antagonists

Prodrugs of clopidogrel's active metabolite identified by Shanghai Curegene Pharmaceutical

Femtogenix discovers new antibody-drug conjugates for cancer

Merck & Co. synthesizes new influenza virus Cap-dependent endonuclease inhibitors

v7D, varicella vaccine candidate with promising safety and immunogenicity in nonhuman primates

Financing at Plexium supports progression of pipeline of targeted protein degradation therapies

Jnana selects JNT-517 as development candidate for phenylketonuria

ConserV receives funding to advance pan-coronavirus vaccine candidate UNICOR-v

Identification of novel antifungal and antibacterial compounds

IL-9/ARG1/macrophage axis targeting for the treatment of allergic airway inflammation

GliaPharm and Wyss Center collaborate on new treatments for Alzheimer's disease

Risk SNP for COVID-19 signals protection against HIV

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...